Kate McCabe
Conseiller Juridique Général chez SAVARA INC.
Provenance du réseau au premier degré de Kate McCabe
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
23
| Public Company | Pharmaceuticals: Major | 23 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kate McCabe via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BORGWARNER INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Treasurer | |
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| Rhone-Poulenc Rorer SA | Corporate Officer/Principal | ||
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
Roche Diagnostics KK
 Roche Diagnostics KK Medical SpecialtiesHealth Technology Part of Roche Holding AG, Roche Diagnostics KK is a Japanese company that manufactures and sells medical equipment. The company is based in Tokyo, Japan. The company was founded in 1932. The CEO is Shin Ogasawara. | Medical Specialties | Corporate Officer/Principal | |
| KINDRED BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MODALIS THERAPEUTICS CORPORATION | Biotechnology | Director/Board Member | |
Neuropore Therapies, Inc.
 Neuropore Therapies, Inc. Medical/Nursing ServicesHealth Services Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
| University of Illinois College of Medicine | College/University | Doctorate Degree | |
| RELIEF THERAPEUTICS HOLDING SA | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Helsinki | College/University | Doctorate Degree | |
| Aalto University School of Business | College/University | Masters Business Admin | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| CUMBERLAND PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Georgia | College/University | Undergraduate Degree | |
| ACUCELA INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| Washington Biotechnology & Biomedical Association | Director/Board Member | ||
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Eisai Medical Research, Inc. | Chief Tech/Sci/R&D Officer | ||
| University of London | College/University | Doctorate Degree | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 30 |
| Japon | 5 |
| Irlande | 4 |
| Suisse | 4 |
| Finlande | 3 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
| Producer Manufacturing | 2 |
Opérationnelle
| Director/Board Member | 95 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 29 |
| Chief Executive Officer | 23 |
| Founder | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Yuri Pikover | 25 |
| Ricky Sun | 24 |
| Richard Hawkins | 21 |
| Joseph McCracken | 20 |
| Nevan Elam | 16 |
| Matthew Pauls | 15 |
| David Ramsay | 13 |
| An van Es-Johansson | 13 |
| Raymond Pratt | 11 |
| Taneli Jouhikainen | 11 |
| Peter L. Ginsberg | 11 |
| David Lowrance | 10 |
| Robert Norman Neville | 10 |
| Badrul Chowdhury | 8 |
| Scott Wilhoit | 7 |
- Bourse
- Insiders
- Kate McCabe
- Connexions Sociétés
